INTRODUCTION: An integrated PET/MRI scanner has been used in selected cases of pediatric brain tumor patients to obtain additional metabolic information about lesions for preoperative biopsy planning and navigation. PATIENTS AND METHODS: Four patients, age 9-16 years, received PET/MRI scans employing [(11)C]methionine positron emission tomography (PET) and contrast-enhanced 3D-MR sequences for neuronavigation. PET and MR sequences have been matched for neurosurgical guidance. An infrared camera-based neuronavigation system was employed with co-registered MR and PET images fused to hybrid images for preoperative planning, stereotactic biopsy planning, and/or intraoperative guidance. RESULTS: All patients showed hot spots of increased amino acid transport in PET and contrast-enhancing lesions in MRI. In three of the four patients, PET hot spots were congruent with contrast-enhancing areas in MRI. In two patients, frame-based stereotactic biopsies were taken from thalamo-mesencephalic lesions. One patient underwent second-look surgery for the suspicion of recurrent malignant glioma of the posterior fossa. One incidental frontal mass lesion was subtotally resected. No complications occurred. Hybrid imaging was helpful during the procedures to obtain representative histopathologic specimens and for surgical guidance during resection. Co-registered images did match with intraoperative landmarks, tumor borders, and histopathologic specimens. CONCLUSION: The integrated PET/MRI scanner offers co-registered multimodal, high-resolution data for neuronavigation with reduced radiation exposure compared to PET/CT scans. One examination session provides all necessary data for neuronavigation and preoperative planning, avoiding additional anesthesia in the small patients. Hybrid multimodality imaging may improve safety and yield additional information when obtaining representative histopathologic specimens of brain tumors.
INTRODUCTION: An integrated PET/MRI scanner has been used in selected cases of pediatric brain tumorpatients to obtain additional metabolic information about lesions for preoperative biopsy planning and navigation. PATIENTS AND METHODS: Four patients, age 9-16 years, received PET/MRI scans employing [(11)C]methionine positron emission tomography (PET) and contrast-enhanced 3D-MR sequences for neuronavigation. PET and MR sequences have been matched for neurosurgical guidance. An infrared camera-based neuronavigation system was employed with co-registered MR and PET images fused to hybrid images for preoperative planning, stereotactic biopsy planning, and/or intraoperative guidance. RESULTS: All patients showed hot spots of increased amino acid transport in PET and contrast-enhancing lesions in MRI. In three of the four patients, PET hot spots were congruent with contrast-enhancing areas in MRI. In two patients, frame-based stereotactic biopsies were taken from thalamo-mesencephalic lesions. One patient underwent second-look surgery for the suspicion of recurrent malignant glioma of the posterior fossa. One incidental frontal mass lesion was subtotally resected. No complications occurred. Hybrid imaging was helpful during the procedures to obtain representative histopathologic specimens and for surgical guidance during resection. Co-registered images did match with intraoperative landmarks, tumor borders, and histopathologic specimens. CONCLUSION: The integrated PET/MRI scanner offers co-registered multimodal, high-resolution data for neuronavigation with reduced radiation exposure compared to PET/CT scans. One examination session provides all necessary data for neuronavigation and preoperative planning, avoiding additional anesthesia in the small patients. Hybrid multimodality imaging may improve safety and yield additional information when obtaining representative histopathologic specimens of brain tumors.
Authors: Koen Mertens; Marjan Acou; Jel Van Hauwe; Ine De Ruyck; Caroline Van den Broecke; Jean-Pierre Okito Kalala; Yves D'Asseler; Ingeborg Goethals Journal: Clin Nucl Med Date: 2013-07 Impact factor: 7.794
Authors: Benoit J M Pirotte; Alphonse Lubansu; Nicolas Massager; David Wikler; Patrick Van Bogaert; Marc Levivier; Jacques Brotchi; Serge Goldman Journal: J Neurosurg Pediatr Date: 2010-05 Impact factor: 2.375
Authors: Benoit J M Pirotte; Alphonse Lubansu; Nicolas Massager; David Wikler; Patrick Van Bogaert; Marc Levivier; Jacques Brotchi; Serge Goldman Journal: J Neurosurg Pediatr Date: 2010-05 Impact factor: 2.375
Authors: Bernhard Sattler; Thies Jochimsen; Henryk Barthel; Kerstin Sommerfeld; Patrick Stumpp; Karl-Titus Hoffmann; Matthias Gutberlet; Arno Villringer; Thomas Kahn; Osama Sabri Journal: MAGMA Date: 2012-10-09 Impact factor: 2.310
Authors: Farzin Imani; Fernando E Boada; Frank S Lieberman; Denise K Davis; Erin L Deeb; James M Mountz Journal: J Neuroimaging Date: 2010-12-14 Impact factor: 2.486
Authors: Hans F Wehrl; Julian Schwab; Kathy Hasenbach; Gerald Reischl; Ghazaleh Tabatabai; Leticia Quintanilla-Martinez; Filip Jiru; Kamila Chughtai; Andras Kiss; Funda Cay; Daniel Bukala; Ron M A Heeren; Bernd J Pichler; Alexander W Sauter Journal: Cancer Res Date: 2013-01-23 Impact factor: 12.701
Authors: Frits Thorsen; Brett Fite; Lisa M Mahakian; Jai W Seo; Shengping Qin; Victoria Harrison; Sarah Johnson; Elizabeth Ingham; Charles Caskey; Terje Sundstrøm; Thomas J Meade; Patrick N Harter; Kai Ove Skaftnesmo; Katherine W Ferrara Journal: J Control Release Date: 2013-10-29 Impact factor: 9.776
Authors: Franz Wolfgang Hirsch; Bernhard Sattler; Ina Sorge; Lars Kurch; Adrian Viehweger; Lutz Ritter; Peter Werner; Thies Jochimsen; Henryk Barthel; Uta Bierbach; Holger Till; Osama Sabri; Regine Kluge Journal: Pediatr Radiol Date: 2013-01-11
Authors: Dale L Bailey; Henryk Barthel; Thomas Beyer; Ronald Boellaard; Brigitte Gückel; Dirk Hellwig; Hans Herzog; Bernd J Pichler; Harald H Quick; Osama Sabri; Klaus Scheffler; Heinz P Schlemmer; Nina F Schwenzer; Hans F Wehrl Journal: Mol Imaging Biol Date: 2013-08 Impact factor: 3.488
Authors: Cornelius Deuschl; Christoph Moenninghoff; Sophia Goericke; Julian Kirchner; Susanne Köppen; Ina Binse; Thorsten D Poeppel; Harald H Quick; Michael Forsting; Lale Umutlu; Ken Herrmann; Joerg Hense; Marc Schlamann Journal: Eur J Nucl Med Mol Imaging Date: 2017-03-03 Impact factor: 9.236
Authors: D L Bailey; G Antoch; P Bartenstein; H Barthel; A J Beer; S Bisdas; D A Bluemke; R Boellaard; C D Claussen; C Franzius; M Hacker; H Hricak; C la Fougère; B Gückel; S G Nekolla; B J Pichler; S Purz; H H Quick; O Sabri; B Sattler; J Schäfer; H Schmidt; J van den Hoff; S Voss; W Weber; H F Wehrl; T Beyer Journal: Mol Imaging Biol Date: 2015-06 Impact factor: 3.488
Authors: Cornelius Deuschl; Sophia Goericke; Johannes Grueneisen; Lino Morris Sawicki; Juliane Goebel; Nicolai El Hindy; Karsten Wrede; Ina Binse; Thorsten Poeppel; Harald Quick; Michael Forsting; Joerg Hense; Lale Umutlu; Marc Schlamann Journal: PLoS One Date: 2016-12-01 Impact factor: 3.240